Evaluation Protocols for Isolation of Analytes From Urine for Future Oncology Applications

NAActive, not recruitingINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

June 18, 2020

Primary Completion Date

November 30, 2023

Study Completion Date

December 31, 2023

Conditions
Breast CancerProstate CancerUrineLiquid Biopsy
Interventions
DEVICE

Colli-Pee UAS devices

Colli-Pee UAS device variants will be evaluated during this study

Trial Locations (1)

2650

Universitair ziekenhuis Antwerpen, Edegem

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Universiteit Antwerpen

OTHER

lead

Novosanis NV

INDUSTRY

NCT05453604 - Evaluation Protocols for Isolation of Analytes From Urine for Future Oncology Applications | Biotech Hunter | Biotech Hunter